A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Moderna, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 356,500 shares of MRNA stock, worth $13.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
356,500
Holding current value
$13.1 Million
% of portfolio
0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$63.64 - $125.14 $22.7 Million - $44.6 Million
356,500 New
356,500 $23.8 Million
Q1 2024

May 15, 2024

SELL
$85.37 - $115.44 $2.67 Million - $3.61 Million
-31,300 Reduced 89.94%
3,500 $372,000
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $2.42 Million - $3.63 Million
34,800 New
34,800 $3.46 Million
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $2.83 Million - $3.84 Million
23,900 New
23,900 $2.9 Million
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $1.8 Million - $3.34 Million
-14,225 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $101 Million - $165 Million
-447,800 Reduced 96.92%
14,225 $3.61 Million
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $31.5 Million - $68.7 Million
-141,900 Reduced 23.5%
462,025 $178 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $58 Million - $105 Million
446,100 Added 282.65%
603,925 $142 Million
Q1 2021

May 17, 2021

SELL
$109.18 - $185.98 $48.4 Million - $82.4 Million
-443,200 Reduced 73.74%
157,825 $20.7 Million
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $32.7 Million - $84.6 Million
497,825 Added 482.39%
601,025 $62.8 Million
Q3 2020

Nov 16, 2020

BUY
$54.34 - $94.85 $5.61 Million - $9.79 Million
103,200 New
103,200 $7.3 Million
Q2 2020

Aug 14, 2020

SELL
$29.67 - $80.0 $225,492 - $608,000
-7,600 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$17.78 - $31.58 $135,128 - $240,008
7,600 New
7,600 $228,000
Q3 2019

Nov 14, 2019

SELL
$12.26 - $18.07 $154,476 - $227,682
-12,600 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$13.7 - $28.34 $172,620 - $357,084
12,600 New
12,600 $184,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.